rs542226383
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_000552.5(VWF):c.1870G>A(p.Gly624Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000814 in 1,535,284 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000552.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VWF | NM_000552.5 | c.1870G>A | p.Gly624Ser | missense_variant | 15/52 | ENST00000261405.10 | |
VWF | XM_047429501.1 | c.1870G>A | p.Gly624Ser | missense_variant | 15/52 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VWF | ENST00000261405.10 | c.1870G>A | p.Gly624Ser | missense_variant | 15/52 | 1 | NM_000552.5 | P1 | |
VWF | ENST00000538635.5 | n.420+53583G>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes ? AF: 0.000197 AC: 30AN: 152206Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000389 AC: 51AN: 131258Hom.: 1 AF XY: 0.000377 AC XY: 27AN XY: 71552
GnomAD4 exome AF: 0.0000694 AC: 96AN: 1382960Hom.: 1 Cov.: 32 AF XY: 0.0000557 AC XY: 38AN XY: 682566
GnomAD4 genome ? AF: 0.000190 AC: 29AN: 152324Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 13AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 26, 2023 | Variant summary: VWF c.1870G>A (p.Gly624Ser) results in a non-conservative amino acid change located in the VWF/SSPO/Zonadhesin-like, cysteine-rich domain (IPR014853) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00038 in 162640 control chromosomes (gnomAD), predominantly at a frequency of 0.0049 within the East Asian subpopulation in the gnomAD database, including 1 homozygote. c.1870G>A has been reported in the literature in at least one compound heterozygous individual carrying a known second pathogenic variant who was affected with Von Willebrand Disease Type 2a (Liang_2017). However, since this individual was adopted, it is unknown if disease was autosomal dominant or recessive in nature. Therefore, these data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submitter has assessed the variant since 2014: the variant was classified as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Oct 01, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at